Abstract:Background: Regulatory DCs are important in tolerance maintenance, whereas the mechanisms for maintaining their immunosuppressive function in immune microenvironment remain unclear. Results: Fas signal enhances the immunosuppressive function of splenic stroma-educated regulatory DCs via the ERK/β-catenin pathway. Conclusion: Fas signal, at least from activated T cells, enhances regulatory function of regulatory DCs. Significance: This study provides new mechanistic insight for immune homeostasis. Dendritic cells (DCs) play important roles in the initiation of immune response and also in the maintenance of immune tolerance. Now, many kinds of regulatory DCs with different phenotypes have been identified to suppress immune response and contribute to the control of autoimmune diseases. However, the mechanisms by which regulatory DCs can be regulated to exert the immunosuppressive function in the immune microenvironment remain to be fully investigated. In addition, how T cells, once activated, can feedback affect the function of regulatory DCs during immune response needs to be further identified. We previously identified a unique subset of CD11bhiIalow regulatory DCs, differentiated from mature DCs or hematopoietic stem cells under a stromal microenvironment in spleen and liver, which can negatively regulate immune response in a feedback way. Here, we show that CD11bhiIalow regulatory DCs expressed high level of Fas, and endothelial stromal cell-derived TGF-β could induce high expression of Fas on regulatory DCs via ERK activation. Fas ligation could promote regulatory DCs to inhibit CD4+ T cell proliferation more significantly. Furthermore, Fas ligation preferentially induced regulatory DCs to produce IL-10 and IP-10 via ERK-mediated inactivation of GSK-3 and subsequent up-regulation of β-catenin. Interestingly, activated T cells could promote regulatory DCs to secrete more IL-10 and IP-10 partially through FasL. Therefore, our results demonstrate that Fas signal, at least from the activated T cells, can promote the immunosuppressive function of Fas-expressing regulatory DCs, providing a new manner for the regulatory DCs to regulate adaptive immunity.

BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells.

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.

A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2

Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice

Interactions that define the arrangement of sugar-binding sites in BDCA-2 and dectin-2 dimers

Lymphoid origin of a lineage of intrinsically activated plasmacytoid dendritic cell in mice and humans

Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells Via the ERK/β-catenin Pathway.

Identification of a novel type I cytokine receptor CRL2 preferentially expressed by human dendritic cells and activated monocytes

Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling

TLR2-dependent Activation of Β-Catenin Pathway in Dendritic Cells Induces Regulatory Responses and Attenuates Autoimmune Inflammation.

Murine Thymic Plasmacytoid Dendritic Cells

pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T cells

Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells

CCDC134 Facilitates T Cell Activation Through the Regulation of Early T Cell Receptor Signaling.

Fc Receptor–like 1 Intrinsically Recruits C-Abl to Enhance B Cell Activation and Function

CD300 molecule regulation of human dendritic cell functions

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation

An Immunomodulatory Antibody-Drug Conjugate Targeting BDCA2 Strongly Suppresses Plasmacytoid Dendritic Cell Function and Glucocorticoid Responsive Genes